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Research
Although broad consensus exists in the 
  scientific community that benzene is a leuke-
mogen, there is considerable uncertainty regard-
ing the actual shape of the exposure–response 
curve (ERC) (Crump 1996; Paustenbach 
et al. 1993). Most of the current epidemio-
logic evidence for an increased leukemia risk 
stems from studies among workers exposed to 
relatively high levels of benzene [McDonald 
2001; U.S. Environmental Protection Agency 
(EPA) 1998]. The risks of leukemia at lower 
benzene exposures, however, remain largely 
unclear. Importantly, exposure to benzene in 
occupational settings has dropped consider-
ably during the last three decades (Capleton 
and Levy 2005). Furthermore, a large propor-
tion of the general population is exposed to 
low levels of benzene (< 0.2 ppm) through car 
exhaust, cigarette smoke, and other sources 
(Johnson et al. 2007). Therefore, the primary 
interest of current benzene risk assessment is 
in risks associated with exposure to low levels 
of benzene.
In existing risk assessments of benzene, the 
ERC was assessed based on evidence from one 
“best” study or, alternatively, from a limited set 
of “best” studies (McDonald 2001; U.S. EPA 
1998). These investigations were mostly con-
ducted among relatively highly exposed work-
ers, so the derived ERC might not be directly 
applicable to workers exposed to lower levels or 
to the general population. Furthermore, these 
risk assessments used linear models to describe 
the ERC, but increasing evidence from molec-
ular epidemiologic studies of workers exposed 
to a wide range of benzene levels indicates that 
the shape of the ERC for benzene and its toxic 
effects may be nonlinear. This hypothesis is 
based on the observation that the dose-related 
production of urinary metabolites of benzene, 
which include the toxic metabolites muconic 
acid and hydroquinone and the less toxic 
metabolites phenol and catechol, decreases with 
increasing benzene exposure (Kim et al. 2006a, 
2006b; Rothman et al. 1998). Furthermore, 
some evidence shows that benzene metabolism 
favors the production of the toxic metabo-
lites hydroquinone and muconic acid at low 
exposures (Kim et al. 2006a). This is especially 
important because hydroquinone is the precur-
sor of 1,4-benzoquinone, which is generally 
regarded as the most hematotoxic metabolite of 
benzene (Kim et al. 2006a). The nonlinear pro-
duction of benzene’s toxic metabolites would 
have important consequences for risk assess-
ment because one would expect this to result 
in a nonlinear relationship between benzene 
exposure and health outcomes as well. Indeed, 
in a study that looked at the shape of the dose– 
response curve of benzene-related hematologic 
effects, a sharper drop in the peripheral white 
blood cell count was observed at lower levels of 
exposure (< 1 ppm) than at higher levels (Lan 
et al. 2004, 2006).
To explore the shape of the benzene–
leukemia ERC, we performed flexible meta-
regressions on a set of studies that reported 
results from quantitative exposure–response 
analysis or benzene and leukemia. For our 
analyses, we used a modified version of the 
approach proposed by Bagnardi et al. (2004) 
that was applied to studies on alcohol and 
mortality and on silica and lung cancer 
(Lacasse et al. 2009). It consists of fitting a set 
of regression models that includes (flexible) 
regression splines and linear models to aggre-
gated data, adjusting for the expected correla-
tion of estimated (relative) risks within studies. 
An improvement of this approach over exist-
ing meta-regression methods is that the use of 
regression splines eliminates the need to make 
strict a priori assumptions regarding the shape 
of the ERC, which allows for a more objective 
evaluation of its actual shape.
Materials and Methods
Identification of studies and evaluation of 
study quality. Publications eligible for the 
meta-regression were identified by a PubMed 
search that included the MESH key words 
“benzene,” “humans,” and “leukemia” in com-
bination with either “cohort studies” or “case–
control studies.” Other publications were added 
by following references included in a literature 
review by Schnatter et al. (2005) that was iden-
tified in the original PubMed search and in 
regulatory risk assessments by the Canadian 
Centre for Occupational Health and Safety, 
the U.S. National Institute for Occupational 
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Ba c k g r o u n d: Previous evaluations of the shape of the benzene–leukemia exposure–response curve 
(ERC) were based on a single set or on small sets of human occupational studies. Integrating evi-
dence from all available studies that are of sufficient quality combined with flexible meta-regression 
models is likely to provide better insight into the functional relation between benzene exposure and 
risk of leukemia.
oBjectives: We used natural splines in a flexible meta-regression method to assess the shape of the 
benzene–leukemia ERC.
Me t h o d s : We fitted meta-regression models to 30 aggregated risk estimates extracted from nine 
human observational studies and performed sensitivity analyses to assess the impact of a priori 
assessed study characteristics on the predicted ERC.
re s u l t s: The natural spline showed a supralinear shape at cumulative exposures less than 100 ppm-
years, although this model fitted the data only marginally better than a linear model (p = 0.06). 
Stratification based on study design and jackknifing indicated that the cohort studies had a consid-
erable impact on the shape of the ERC at high exposure levels (> 100 ppm-years) but that predicted 
risks for the low exposure range (< 50 ppm-years) were robust.
co n c l u s i o n s: Although limited by the small number of studies and the large heterogeneity between 
studies, the inclusion of all studies of sufficient quality combined with a flexible meta-regression 
method provides the most comprehensive evaluation of the benzene–leukemia ERC to date. The 
natural spline based on all data indicates a significantly increased risk of leukemia [relative risk 
(RR) = 1.14; 95% confidence interval (CI), 1.04–1.26] at an exposure level as low as 10 ppm-years.
key w o r d s : benzene, epidemiology, leukemia, meta-regression, quantitative risk assessment. 
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Safety and Health, the U.S. Agency for Toxic 
Substances and Disease Registry, and the U.S. 
EPA (Agency for Toxic Substances and Disease 
Registry 2007; U.S. National Institute for 
Occupational Safety and Health 1976; Penney 
1995; U.S. EPA 1998). The quality of the 11 
studies that reported results from quantitative 
exposure–response analysis for benzene and 
leukemia (mortality or incidence) was evalu-
ated using a previously developed evaluation 
framework (Vlaanderen et al. 2008). The first 
tier of the framework consisted of six criteria 
that are related to crucial aspects of the qual-
ity of the design, the quality of conduct, and 
the quality of the reporting of human obser-
vational studies [see Supplemental Material 
(doi:10.1289/ehp.0901127)]. A study was 
excluded from the meta-regression if it did not 
meet all of the six criteria. Nine studies were of 
sufficient quality to be included in the meta-
regression (Table 1). Two studies that reported 
results from quantitative exposure–response 
analysis were excluded: One expressed expo-
sure in undefined units (Guénel et al. 2002), 
and the other provided insufficient details that 
resulted in a lack of insight regarding the deci-
sions made in the statistical analysis (Collins 
et al. 2003).
Extraction of data from the incorporated 
studies. A database was constructed based on 
published data available for the studies incor-
porated in the meta-regression. We extracted 
only risk estimates reported for cumulative 
exposure to benzene (expressed in ppm-years 
or ppm-months). The database contained the 
following fields: study identifier, study design, 
exposure category, risk estimate, confidence 
interval for the risk estimate, and number of 
cases and controls for each exposure category 
(nested case–control studies) or the size of the 
study population for the exposure category 
(cohort studies). Three different epidemio-
logic study designs contributed to the current 
meta-  regression: the nested case–control design 
(n = 3), the cohort design with an internal refer-
ence population (n = 1), and the cohort design 
with an external reference population (n = 5; 
Table 1). Reported odds ratios (ORs), relative 
risks (RRs), and standardized mortality ratios 
(SMRs) were combined and interpreted as esti-
mates of the RR for the purpose of this meta-
regression (McElvenny et al. 2004). The studies 
selected for the meta-regression were also differ-
ent with regard to the definition of the reference 
population that was used. The cohort studies 
assumed “background (environmental) expo-
sure” in their reference populations (Bloemen 
et al. 2004; Costantini et al. 2003; Hayes et al. 
1997; Rinsky et al. 2002; Swaen et al. 2005; 
Wong 1987). Typical daily environmental 
exposure to benzene can range up to 0.2 ppm, 
which, over a 70-year life span, accumulates 
to a maximum of 14 ppm-years of cumulative 
exposure (Johnson et al. 2007). In the nested 
case–control studies, individuals in the lowest 
exposure category were used as the reference 
population (ranging from < 0.17 ppm-years to 
< 1 ppm-years occupational exposure) (Glass 
et al. 2003; Rushton and Romaniuk 1997; 
Schnatter et al. 1996).
Preparation of the data extracted from the 
publications. Three steps were necessary to pre-
pare the extracted data for use in the meta-
regression models. In the first step, we assigned 
a specific cumulative exposure estimate to each 
risk estimate. It is common practice to report 
only the boundaries of the exposure categories 
used in an exposure–response analysis, and this 
was the case for all included studies except the 
Swaen study, which reported an average mean 
exposure (Greenland and Longnecker 1992; 
Swaen et al. 2005). To estimate the mean 
exposure for the assigned exposure categories, 
we assumed a log-normal distribution for the 
cumulative exposure for each study. Any data 
providing information on the exposure distri-
bution within a study were collected from the 
publication (i.e., the number of   person-years 
per exposure category, the number of con-
trols per exposure category, or the number 
of expected cases per exposure category). 
Maximum likelihood estimation was used to 
fit a probability density function (PDF) to the 
available data. Using the PDF, we assigned an 
average cumulative exposure to each exposure 
category based on its respective boundaries. To 
avoid unreasonably high estimates of the aver-
age exposure in the highest exposure group, 
we truncated the exposure distribution at the 
maximum reported cumulative exposure level. 
This method of assigning specific cumulative 
exposures is similar to the approach that was 
proposed by Hartemink et al. (2006).
In the second step, we estimated the vari-
ance of each specific risk estimate to allow 
Table 1. Details of the studies included in the meta-regression.
Reference (study) Study design
Risk  
estimates Country Industry
Reference  
category
Exposure category 
(ppm-years) Study 
outcome
ICD code 
(revision)b Study population size  Lowesta Upper
Wong et al. 1987 Cohort SMR USA Chemical industry National population 
death rates
< 15  ≥ 60 Mortality 204–207 (8) 7,676 individuals, 6 cases
Hayes et al. 1997
(CAPM-NCI)c
Cohort RR China Variety of industries Workers employed in 
work units or factories 
where benzene was 
not used
< 40 > 100 Incidence 204–208 (9) 74,828 exposed, 35,805 
unexposed, 47 cases
Rinksy et al. 2002
(Pliofilm)
Cohort SMR USA Chemical industry National population 
death rates
0.01–40 > 400 Mortality 204–208d 1,291 individuals, 15 cases
Costantini et al. 2003 Cohort SMR Italy Shoe factory National and regional 
specific death rates
< 40 > 200 Mortality 204–207 (8) 1,687 individuals, 11 cases
Bloemen et al. 2004 
(Dow)
Cohort SMR USA Chemical industry National and regional 
specific death rates
< 28.3 > 79.1 Mortality 204–208 (9) 2,266 individuals, 12 cases
Swaen et al. 2005e Cohort SMR Netherlands Chemical industry National population 
death rates
3.4 401.5 Mortality NAf 311 individuals, 1 case
Schnatter et al. 1996 
(Canada Petrol)
Nested 
case–control
OR Canada Petroleum industry Workers exposed to  
< 0.17 ppm-years
0.18–0.49 8–219.8 Incidence 204–207 (8) 14 cases, 55 controls
Rushton and 
Romaniuk 1997 
(UK-Petrol)
Nested 
case–control
OR UK Petroleum industry Workers exposed to  
< 0.26 ppm-years
0.26–0.59 > 4.79 Mortality/
incidence
204–208 (9) 90 cases, 354 controls
Atkinson et al. 2001; 
Glass et al. 2003 
(AHW)
Nested  
case–control
OR Australia Petroleum industry Workers exposed to  
≤ 1 ppm-years
1–2 > 16 Incidence 204–208 (9) 33 cases, 165 controls
Abbreviations: AHW, Australian Health Watch; CAPM-NCI, Chinese Academy of Preventive Medicine–National Cancer Institute; NA, not applicable; OR, odds ratio; RR, relative risk; 
SMR, standardized mortality ratio; UK, United Kingdom. 
aLowest exposure category for which a risk estimate was reported (excluding reference category). bInternational Classification of Diseases (ICD) used for disease outcomes related to 
“leukemia”: 204, lymphoid leukemia; 205, myeloid leukemia; 206, monocytic leukemia; 207, other specified leukemia; 208, leukemia of unspecified cell type [World Health Organization (WHO) 
1967, 1977]. cStudy with internal reference group. dICD code for “leukemia” category in effect at time of death of the cases. eAverage mean exposure for tertiles of the exposure distribution; 
because of a lack of observed cases, a risk estimate was reported only for the middle tertile. fDisease categorization based on the Dutch electronic file of causes of death.Vlaanderen et al.
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weighting based on the precision of the risk 
estimates in the meta-regression (DerSimonian 
and Laird 1986). The variance of RRs and 
ORs was estimated using the reported confi-
dence intervals following a method discussed 
by Rothman et al. (1982). Estimated variances 
for studies that reported asymmetrical confi-
dence intervals on the log scale were based on 
the upper confidence limit only (Boice and 
McLaughlin 2001; Wartenberg et al. 2000).
In the third step, we estimated the cova-
riance between the different risk estimates 
within a study by applying the approach 
advocated by Shi and Copas (2004). This 
approach is necessary because risk estimates of 
a study based on a common internal reference 
group will be correlated. Ignoring this cor-
relation in the meta-regression underestimates 
the variance of the risk estimates from the 
study that results in an overestimation of its 
weight (Bagnardi et al. 2004; Greenland and 
Longnecker 1992). The Canada-Petrol study 
(Schnatter et al. 1996) lacked the information 
necessary to estimate the covariance matrix; 
therefore, uncorrected variances were used for 
this study. For studies that reported SMRs, 
we did not estimate covariance because SMRs 
within a single study can be assumed to be 
largely independent when the expected num-
ber of deaths used to calculate the SMRs is 
based on a sufficiently large population.
Application of the (regression) models 
to describe the exposure–response relation. 
Natural spline models (with knots at the 20th, 
50th, and 80th percentiles) as well as linear 
models were fitted to the data to investigate 
the shape of the exposure–response relation. 
To improve the statistical properties of the 
regression models, we fitted all models to the 
natural logarithm of the reported risk estimates 
(Berlin et al. 1993). Regression models were 
fitted to the data using a modified version of 
a macro developed by Bagnardi et al. (2004). 
All regression models allowed for (random) 
study-specific intercepts and exposure effects 
to accommodate potential between-study 
hetero  geneity (DerSimonian and Laird 1986). 
Model deviance was used to compare goodness 
of fit between (nested) models.
Sensitivity analyses. For two cohort stud-
ies Pliofilm (Rinsky et al. 2002) and Dow 
(Bloemen et al. 2004) multiple updates were 
available (Table 1). These updates represent 
multiple reports on the same cohort. In the 
most recent report, researchers had the oppor-
tunity to follow the participants for the longest 
time since the start of the follow-up period.
For these cohorts, the most recent update was 
included in the meta-regression. To assess the 
impact of varying follow-up times in our anal-
ysis, we also conducted the meta-  regression 
with risk estimates that were abstracted from 
earlier updates of the Pliofilm and Dow 
Figure 1. Scatter plot of the risk estimates extracted from the nine studies included in the meta-regression, based on the assigned average cumulative exposure: 
Full range of cumulative exposures (A) and cumulative exposures < 50 ppm-years (B). AHW, Australian Health Watch.
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Figure 2. Predicted ERC using all risk estimates 
from the nine included studies based on a natu-
ral spline and linear regression model. Plot 1 is 
the predicted ERC based on a linear model. Plot 
2 is the predicted ERC based on a natural spline 
model (knots are located at 2.9, 22.7, and 125.5 
ppm-years). Dashed lines represent the 95% CIs of 
the predictions. Rug plot indicates the distribution 
of the estimated cumulative exposure for each risk 
estimate included in the analyses.
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Figure 3. Sensitivity analysis on the prediction of 
the ERC based on a natural spline. Graph repre-
sents nine plots of the predicted ERC based on all 
studies minus one. The plots are identified by the 
study that was excluded: 1, CAPM-NCI; 2, Dow; 3, 
Costantini; 5, US-Chemical (Wong et al. 1987); 6, 
Swaen; 7, Canada-Petrol; 8, AHW; 9, UK-Petrol; and 
10, Pliofilm. Plot 4 is the predicted ERC based on all 
available studies (blue line). Abbreviation: AHW, 
Australian Health Watch.
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cohorts (Bond et al. 1986; Rinsky et al. 1987). 
Substitution of the risk estimates did not 
have a substantial effect on the shape of the 
predicted ERC or on model fit to the data 
(data not shown). Sensitivity of the predicted 
ERC to the inclusion of specific studies was 
assessed with a jackknifing analysis, excluding 
one study at a time before (re)predicting the 
exposure–response relation. In addition, we 
analyzed the cohort studies (including those 
with an external reference group as well as the 
single study with an internal reference group) 
and nested case–control studies separately and 
compared their ERC predictions. To allow 
flexible prediction of the ERC, all sensitivity 
analyses were done using natural splines.
Prediction of risk estimates. Benzene–
leukemia ERC RRs were estimated for four 
plausible scenarios at three different levels 
of cumulative exposure (10, 20, and 40 
ppm-years, corresponding to 0.25, 0.5, and 
1 ppm intensity of exposure over a tenure of 
40 years). We used fitted regression models 
to predict the risk estimates with associated 
confidence intervals. In addition, corrected 
risk estimates and confidence intervals were 
calculated by subtracting the intercept at zero 
exposure predicted by the regression model 
from the risk estimates.
Software. Average exposure levels for 
reported exposure categories were estimated 
using R, version 2.7 (R Core Development 
Group, Vienna, Austria). All other statistical 
analyses were performed using SAS software 
for Windows (version 9.1, SAS Institute Inc., 
Cary, NC, USA).
Results 
Nine studies had sufficient quality to be 
included in the meta-regression. All included 
studies were performed in the occupational 
setting. Together, these studies provided 30 
risk estimates over a range of 0.32–554.3 
(assigned) ppm-years (Figure 1A). Nineteen 
(63%) of the risk estimates were assigned 
a cumulative exposure <  50  ppm-years 
(Figure 1B). Most of the risk estimates for 
the lower exposure range were provided by 
nested case–control studies. The differences 
in exposure levels between studies can be 
largely attributed to the different industries in 
which the studies were performed. The nested 
case–control studies were all performed in 
the petroleum industry, whereas the cohort 
studies were performed in the chemical indus-
try (Pliofilm, Dow, Wong, and Swaen stud-
ies), in a shoe factory (Costantini study), or 
a wide range of different industries [Chinese 
Academy of Preventive Medicine–National 
Cancer Institute (CAPM-NCI) study] (Hayes 
et al. 1997; Table 1).
Predictions of the ERC based on a natu-
ral spline model and a linear model are pre-
sented in Figure 2. The lower deviance of 
the natural spline (deviance = 25.84, 27 df) 
compared with that of the linear model (devi-
ance = 29.25, 28 df) suggests a slightly better 
fit [chi square test (1 df), p = 0.06]. The natural 
spline model also indicates a strong supralinear 
shape of the ERC in the low-exposure region, 
resulting in a considerable lower intercept than 
the linear model (RR = 1.33 vs. 1.65).
Results from a jackknifing analysis 
(Figure 3) suggest that the Pliofilm and the 
CAPM-NCI studies were particularly influen-
tial for the (high-exposure region of the) pre-
dicted ERC. Exclusion of the Pliofilm study 
from the meta-regression resulted in a strong 
reduction of risks predicted for cumulative 
exposures > 100 ppm-years, whereas exclusion 
of the CAPM-NCI study had the opposite 
effect. Exclusion of other studies had little 
impact on the predicted ERC.
Stratified analyses showed that study 
design had a considerable impact on the pre-
dicted ERC (Figure 4). The ERC based on 
the cohort studies had a similar shape com-
pared with the ERC based on the full data. 
However, the supralinear shape was some-
what less pronounced and the predicted inter-
cept slightly lower (RR = 1.13 vs. 1.33). The 
deviance of the natural spline model fitted to 
the cohort studies was smaller than the devi-
ance of the corresponding linear model [devi-
ance = 8.43 and 11.97 respectively; chi square 
test (1 df), p = 0.06]. The analysis based on 
the three nested case–control studies resulted 
in extremely wide confidence intervals around 
the predicted ERC and was essentially unin-
formative (Figure 4).
We predicted the RRs for leukemia for 
three cumulative exposure levels (10, 20, 40 
ppm-years) based on four different modeling 
scenarios for the shape of the benzene leuke-
mia ERC (Table 2). The four scenarios were a 
natural spline with intercept fitted to all studies 
(scenario A), a natural spline without inter-
cept fitted to all studies (scenario B), a natural 
spline with intercept fitted to the cohort stud-
ies (scenario C), and a linear model without 
intercept fitted to all studies (scenario D1) or 
only the cohort studies (scenario D2; Figure 5). 
Scenario A predicted the highest RRs (1.52, 
1.73, and 2.11 for cumulative exposures of 
10, 20, and 40 ppm-years respectively), 
although these dropped considerably (RR = 
1.14, 1.29, and 1.59) after correction for the 
predicted intercept. RRs predicted in scenario 
B (RR = 1.22, 1.46, and 1.96) were some-
what lower than the uncorrected RRs from 
scenario A. Predictions using data from the 
cohort studies only (scenario C) were also lower 
than those predicted by scenario A (all studies) 
(RR = 1.25, 1.38, 1.67), although these differ-
ences largely disappeared after we corrected for 
the intercept. Finally, predictions of the RRs 
based on scenario D1 (RR = 1.04, 1.09, 1.19) 
and D2 (RR = 1.05, 1.10, 1.20) were very 
similar and considerably lower than the predic-
tions based on the other scenarios.
Discussion
Interpretation of the predicted ERC. We pre-
sented estimates of the benzene–leukemia 
ERC based on predictions from two regression 
models. Both the natural spline and linear 
regression models indicated a positive rela-
tion between cumulative exposure to benzene 
and leukemia risk, although risk appeared to 
increase more strongly at low exposures in the 
natural spline model. This supralinear shape 
of the natural spline model at low exposures 
is consistent with the increasing evidence that 
saturable metabolism plays an important role 
in the low-dose carcinogenicity of benzene 
(Kim et al. 2006a, 2006b; Lan et al. 2006; 
Rappaport et al. 2002a, 2002b, 2005, 2009; 
Rothman et al. 1998).
Alternative explanations for the non  linear 
relation between (inhalatory) benzene exposure 
Table 2. Comparison of predicted RRs for three cumulative exposure levels.
RR (95% CI)
Model Deviance (df) Intercept 10 ppm-years 20 ppm-years 40 ppm-years
Prediction meta-regression—all studies
Scenario A: natural spline 25.84 (27) 1.33 (0.87–2.05) 1.52 (1.08–2.15) 1.73 (1.27–2.34) 2.11 (1.51–2.96)
Scenario A corrected for intercept 1.14 (1.04–1.26) 1.29 (1.07–1.56) 1.59 (1.15–2.19)
Scenario B: natural spline without intercept 28.39 (28) NA 1.22 (1.11–1.34) 1.46 (1.22–1.75) 1.96 (1.44–2.68)
Scenario D1: linear model without intercept 38.67 (29) NA 1.05 (1.02–1.07) 1.10 (1.05–1.15) 1.20 (1.09–1.32)
Prediction meta-regression—cohort studies
Scenario C: natural spline 8.43 (15) 1.13 (0.71–1.81) 1.25 (0.83–1.88) 1.38 (0.96–1.97) 1.67 (1.22–2.27)
Scenario C corrected for intercept 1.10 (1.04–1.17) 1.22 (1.09–1.36) 1.48 (1.19–1.83)
Scenario D2: linear model without intercept 15.95 (17) NA 1.04 (1.02–1.07) 1.09 (1.04–1.14) 1.19 (1.09–1.31)
NA, not applicable.Vlaanderen et al.
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and leukemia that we found are depletion of 
susceptible individuals at high benzene expo-
sure levels and bias due to attenuation of the 
exposure–response relation within or between 
studies (Stayner et al. 2003). Attenuation of 
exposure–response relations is commonly 
observed in occupational studies and can be 
caused by several factors, including the healthy 
worker survivor effect, high disease back-
ground rates, exposure measurement error, 
and confounding and effect modification 
(Stayner et al. 2003). However, not all of these 
factors are equally likely to have played a role 
in occupational studies on benzene and leu-
kemia. Confounding should be considered a 
potential factor that might have introduced 
attenuation, but none of the included studies 
demonstrated (or was able to demonstrate) a 
confounding effect from potential confound-
ers such as ionizing radiation, smoking, and 
family history of leukemia (Zeeb and Blettner 
1998). In addition, it is unlikely that these 
factors could have caused serious distortion of 
the study findings considering the general lack 
of association with exposure to benzene across 
the assessed industries (ionizing radiation), 
weak association with leukemia (smoking), 
and rare occurrence (family history of leuke-
mia) (Zeeb and Blettner 1998).
Factors that contributed to the heteroge-
neity observed between studies were differ-
ences in study design and exposure assessment. 
Although all studies were comparable regard-
ing the context of exposure (occupational 
exposure), considerable differences exist in the 
geographical location, type of industry, and 
intensity and frequency of exposure to ben-
zene (Table 1). Differences in study design 
resulted in different types of risk estimates 
that were reported: RRs, ORs, and SMRs 
(Table 1). However, ORs and SMRs can be 
interpreted as reasonable approximations of 
the RR when the disease is rare, and these 
measures have been pooled with RRs for meta-
analysis in previous analyses (McElvenny et al. 
2004; Steinmaus et al. 2008). According to 
our evaluation, the quality of exposure assess-
ment was sufficient in all included studies 
(Vlaanderen et al. 2008). However, systematic 
differences in exposure assessment strategies 
between studies might have contributed to 
the between-study heterogeneity. Because all 
included studies assessed exposure retrospec-
tively based on a relatively limited set of expo-
sure measurements, exposure estimation in 
these studies was based partly on decision rules 
to extrapolate exposure measurements to time 
periods and exposure circumstances for which 
no measurements were available (Bloemen 
et al. 2004; Costantini et al. 2003; Glass et al. 
2003; Hayes et al. 1997; Rinsky et al. 2002; 
Rushton and Romaniuk 1997; Schnatter et al. 
1996; Swaen et al. 2005; Wong 1987). The 
significant amount of expert judgment that 
goes into these decision rules makes it con-
ceivable that systematic differences in expo-
sure assessment may exist between studies. 
This situation is illustrated by the exposure 
assessment for the Pliofilm cohort where three 
groups of authors have published three differ-
ent sets of exposure estimates, based on the 
same exposure measurement data (Crump 
1996; Paustenbach et al. 1992; Rinsky et al. 
1987, 2002). In contrast, the three nested 
case–control studies attempted to limit sys-
tematic error in exposure assessment by apply-
ing similar exposure assessment approaches 
(Glass et al. 2003; Rushton and Romaniuk 
1997; Schnatter et al. 1996).
We tried to assess the potential impact of 
between-study heterogeneity in the sensitivity 
analyses. Visual inspection of the results from 
a jackknifing analysis (Figure 3) showed that 
two studies that provided risk estimates for the 
highest assigned cumulative exposures had a 
considerable impact on the ERC for the higher 
exposure range. The impact on the lower expo-
sure range was less pronounced. Exclusion of 
the Australian Health Watch (AHW; Atkinson 
et al. 2001; Glass et al. 2003) study, which 
reported relatively high risks for the low-
  exposure range (Figure 1), had little impact 
on the shape of the ERC. Results from the 
sensitivity analysis stratified by study design 
indicated considerable differences between the 
ERC based on the nested case–control stud-
ies from the petroleum industry and the ERC 
based on the cohort studies. The shape of the 
ERC based on the cohort studies only was 
similar to the shape of the ERC based on all 
studies. Although the shape of the ERC for the 
nested case–control studies could be estimated 
only very imprecisely, the results indicated that 
these studies were largely responsible for the 
rather high intercepts that were predicted for 
the ERCs based on the full data.
Assessing publication bias in a flex-
ible meta-regression is complicated because 
no standard statistical approaches are avail-
able to deal with the correlated effect estimates 
and the nonlinear exposure–response relations. 
However, in our opinion it is unlikely that 
studies with quantitative benzene exposure 
estimates would not have reported risk esti-
mates for leukemia even if these had been 
nega  tive because this is one of the major cancer 
outcomes associated with the exposure. Also, 
considering the large effort that is required to 
generate quantitative benzene exposure esti-
mates, it is improbable that any study that 
had quantitative exposure estimates available 
would not have been published at all.
Considering that risk estimates in the 
included studies were calculated in reference 
to populations with assumed no or negligible 
occupational exposure to benzene, one might 
have expected a predicted marginal intercept 
(ln RR) of approximately 0 (RR = 1) at 0 ppm-
years. Although intercepts above 0 are fre-
quently observed in exposure–response studies 
based on epidemiologic data, most other meta-
regression studies have avoided the issue by 
Figure 5. Four different scenarios for the shape of the benzene–leukemia ERC: Natural spline with intercept 
fitted to all studies (best-fitting model) (A), natural spline without intercept fitted to all studies (B), natural 
spline with intercept fitted to the cohort studies (C), and linear model without intercept (D) fitted to all the 
studies (1) and only the cohort studies (2). Dashed lines are 95% CIs.
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forcing their regression models to fit through 
the origin (Bagnardi et al. 2004; Greenland 
and Longnecker 1992). We did include inter-
cepts in our regression models to attain the 
best possible fit to the data, which resulted 
in intercepts of RRs of 1.33 and 1.65 in the 
natural spline and linear regression models, 
respectively. An explanation for these nonzero 
intercepts may be the lack of risk estimates for 
very low exposure levels (< 0.32 ppm-year). 
Risk estimates at slightly higher, but still very 
low, exposure levels (ppm-years) already indi-
cate a strong increase in risk. A natural spline, 
being linear in its tails, may be unable to track 
the curvature of the ERC at these low levels, 
resulting in a nonzero intercept. The same 
reasoning would apply to intercepts from the 
linear model, although the effect may be even 
more extreme. However we cannot exclude 
the effect of lower-than-expected leukemia risk 
in the reference populations or (conversely) 
higher nonbenzene-related leukemia risk in 
the exposed populations. Finally, attenuation 
of the ERC due to random and systematic 
error in the exposure assessment might also 
have forced the intercept up (Berman and 
Crump 2008; Stayner et al. 2003).
Implications of the findings for quantita-
tive risk assessment (QRA). To facilitate the 
use of our meta-regression results in QRA, we 
provided the benzene leukemia ERC for three 
plausible scenarios (Figure 5, Table 2). In sce-
nario A, the natural spline model was used, 
which fitted the data slightly better than a 
linear model. However, the estimate of leuke-
mia risk at 0 ppm-years (the intercept) for this 
model was much lower than that for the linear 
model. Because application of these models 
for risk assessment purposes will most likely 
entail subtraction of the intercept from all pre-
dictions [effectively lowering the predicted 
(increased) risks for benzene at each exposure 
level], we favor scenario A (Figure 5A) for risk 
prediction over the alternatives (Table 2). If 
one believes that the intercept is due to the 
natural spline failing to track the shape of the 
ERC at very low exposures, one may prefer 
predictions from a spline model without an 
intercept, thus forcing the predicted ERC 
through the origin (scenario B, Figure 5B). 
This model fitted the data only slightly worse 
than scenario A and may therefore be con-
sidered a plausible alternative [chi-square test 
(1 df), p = 0.11]. If one believes that the nested 
case–control studies should not be used for 
prediction of the ERC, scenario C (Figure 5C) 
could be used, which was based on a natural 
spline model with an intercept fitted to data 
from the cohort studies only. This scenario 
resulted in slightly lower predicted risks for 
exposures < 100 ppm-years. Finally, scenarios 
D1 (all studies, Figure 5D) and D2 (cohort 
studies only) were based on linear models 
without an intercept and are therefore similar 
in spirit to models commonly used in QRA 
(McDonald 2001; U.S. EPA 1998) (Figure 
5). Clearly, these models fitted the data clearly 
worse than did the relevant alternative models 
in scenario A [chi-square test (2 df), p = 0.002] 
and scenario C chi-square test (2 df), p = 0.02].
To compare predictions from scenarios 
A–D with predictions from existing QRAs, 
we estimated RRs for three cumulative expo-
sures in the low exposure range (10, 20, and 
40 ppm-years; Table 2). This showed that 
risk estimates from our models at these expo-
sures are very similar to those based on the 
(multiplicative) models used by the U.S. EPA 
and the California Environmental Protection 
Agency in their QRA of benzene (McDonald 
2001; U.S. EPA 1998). However, although 
these QRAs were based on data from either 
the Pliofilm study or the CAPM-NCI study, 
our approach allowed us to use all available 
epidemiologic evidence to date and should 
therefore be more robust. In addition, our 
approach allowed for a nonlinear shape of the 
ERC to be used in QRA, which appears to be 
more appropriate. It is important to note that 
all analyses were performed on the overarch-
ing disease outcome “leukemia.” Slight differ-
ences in the definition of this disease existed 
between studies (Table 1). Unfortunately, 
analyses for specific subtypes of leukemia will 
be hampered by a lack of data.
Conclusion
Flexible meta-regression of the aggregated 
risk estimates from a set of occupational 
human observational studies offers an effi-
cient approach to acquiring more insight in 
the functional relation between exposure to 
benzene and leukemia. The flexible meta-re-
gression model predicted a supralinear shape 
of the ERC. Although the limited number of 
available studies and the large heterogeneity 
between studies were considerable limitations, 
sensitivity analyses demonstrated that results 
were not strongly affected. Our application 
of a flexible meta-regression method provides 
the most comprehensive evaluation of the 
benzene–leukemia ERC to date.
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